This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
OptumRx launched Price Edge, a tool that compares pricing for traditional generic drugs to ensure members get the lowest prescriptiondrugprices. It's a new year, and healthcare technology vendors are rolling out their latest innovations, market approvals, acquisitions and staffing shake-ups.
The ability to book an doctor’s appointment ASAP, care available in-person and via telehealth, and control over my care — these are key factors Zocdoc explains in the company’s What Patients Want report published this week. Of the 9% of male bookings made by someone else, 80% were done so by a woman.
In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescriptiondrugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.
Take Optum, which this week launched the Price Edge tool to help steer patients to the “lowest price generic medicines” according to the program’s press release. The price-comparison tool exclusively focused on generic drugs will be available to Optum Rx members.
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescriptiondrugpricing based on this research. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescriptiondrug spending will be the fastest-growing cause of rising health spending by 2027.
Double-booked surgeries lead to $14.6 Whitmer signs bills designed to lower prescriptiondrugprices in Michigan. General pays $14.6 million to settle whistle-blower suit over concurrent surgeries. Nurses at Massachusetts Tenet hospital hold vote to decertify union following strike. million settlement.
Even seemingly popular plan ideas like prescriptiondrugpricing and coverage for pre-existing conditions can’t get traction in Congress or through the White House’s executive pen. which is a key factor underpinning my argument for health citizenship in America in my book, HealthConsuming: From Health Consumer to Health Citizen.
If you live in greater Atlanta, you’re in luck: prescription medicines are priced about 20% lower than national average there, similarly in Dallas, Houston and Denver. We agreed — prescriptiondrugpricing, from the patient’s point of view, is complicated, indeed.
In my book HealthConsuming: From Health Consumer to Health Citizen, I detail the health microeconomics which explain that low return. prices are greater than in fellow OECD nations: wages are higher for specialist physicians, prices for digital imaging greater, and of course prescriptiondrugprices the highest in the world.
While our health care trade press re-iterates Uwe Reinhardt’s and Gerard Anderson’s observation that, “It’s the prices, stupid” from back in 2003, closer to peoples’ homes and real lives, Consumer Reports and TIME magazine also try and support Americans’ health consumer muscle/brain) development and ethos.
Health Populi’s Hot Points: The third chart illustrates that pharma pricing is a unifying force across older voters across the three political parties. consumers to import cheaper prescriptiondrugs from other countries. While deep understanding of how U.S.
is prescriptiondrugprices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. The biggest culprit/contributor to prescriptiondrugprices? consumers were asked.
With the emergence of six-to-seven figure specialty drugs coming out of the Rx pipeline into commerce, we can expect growing financial toxicity as a side effect of these therapies, and evolving financial services offered to patients to pay, say, on an installment plan as Bluebird Therapeutics has offered (specifically, $1.78
We must hasten to add that Rx CPI was driven down by the influence of generic drugprices in the past year]. As a forecaster, I’m watching this trend as part of my crystal ball-thinking as health consumers morph to health citizens — the theme of my book, HealthConsuming. .
” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to Z,” now in its third edition. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?”
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content